News Quantified

ONVO – organovo holdings, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Yahoo! Finance]

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) [Financial Post (Toronto, Ontario, Canada)]

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering [Yahoo! Finance]

Form 424B4 ORGANOVO HOLDINGS, INC.

Form 8-K ORGANOVO HOLDINGS, INC. For: May 08

Form 424B4 ORGANOVO HOLDINGS, INC.

Form EFFECT ORGANOVO HOLDINGS, INC.

Form 8-K ORGANOVO HOLDINGS, INC. For: May 01

Top News Gainers

5/30 Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease 96.5%

3/31 Form SEC STAFF LETTER ORGANOVO HOLDINGS, INC. 34.4%

12/16 Organovo and Tarveda Therapeutics Announce Definitive Merger Agreement 20.6%

11/14 Organovo Holdings Inc (NASDAQ: ONVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 18.8%

6/28 Form 8-K ORGANOVO HOLDINGS, INC. For: Jun 25 13.9%

4/7 Organovo Announces Termination of Merger Agreement with Tarveda Therapeutics 13.6%

7/10 Form SC 13G/A ORGANOVO HOLDINGS, INC. Filed by: BlackRock Inc. 12.5%

10/2 Organovo Acknowledges Receipt of Proposal 5.6%

10/2 Viscient Biosciences Proposes Merger to Unlock 3D Bioprinting Potential in Drug Discovery With Organovo 3.7%

10/11 Form 8-K ORGANOVO HOLDINGS, INC. For: Oct 10 3.7%

Top News Decliners

5/22 Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results -39.5%

8/7 Organovo to Explore Strategic Alternatives and Implement Restructuring Plan -35.8%

3/31 Organovo Holdings, Inc. Reminds Stockholders About Adjourned Special Meeting of Stockholders -23.7%

5/23 Organovo Holdings, Inc. (ONVO) CEO Taylor Crouch on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -17.0%

4/2 Organovo Holdings Founder Calls on Board of Directors to Accept Stockholders’ Opposition to the Illogical Merger With Tarveda Therapeutics -15.5%

12/30 Form 425 ORGANOVO HOLDINGS, INC. Filed by: ORGANOVO HOLDINGS, INC. -14.0%

1/21 Form PX14A6G ORGANOVO HOLDINGS, INC. Filed by: Murphy Keith -13.1%

3/20 Form 425 ORGANOVO HOLDINGS, INC. Filed by: ORGANOVO HOLDINGS, INC. -10.8%

3/13 Form CT ORDER ORGANOVO HOLDINGS, INC. -10.1%

2/24 Form 424B3 ORGANOVO HOLDINGS, INC. -9.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day